H. Lundbeck A/S today announced the initiation of the first Japanese clinical phase II trial with desmoteplase (DIAS-J) in the treatment of acute ischaemic stroke. This study is required for the approval of the substance for the Japanese market. In 2009 Lundbeck successfully performed a phase I study in around 30 healthy Japanese volunteers with [...]